4//SEC Filing
Namouni Fouad 4
Accession 0001415889-24-007021
CIK 0001597264other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:21 PM ET
Size
14.8 KB
Accession
0001415889-24-007021
Insider Transaction Report
Form 4
Namouni Fouad
PRESIDENT, R & D
Transactions
- Award
Stock Option (Right to Buy)
2024-03-01+30,000→ 30,000 totalExercise: $95.12Exp: 2034-03-01→ Common Stock (30,000 underlying) - Award
Common Stock
2024-03-01+15,000→ 77,080 total
Footnotes (2)
- [F1]The reported transaction involved the Reporting Person's receipt of grant of 15,000 restricted stock units under Issuer's 2015 Stock Option and Incentive Plan.
- [F2]This option vests with respect to 1/48th of the shares underlying the option on April 1, 2024 and as to an additional 1/48th of the shares underlying the option each month thereafter.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001815851
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:21 PM ET
- Size
- 14.8 KB